AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "T"
Results 191 - 200 of 354 shown below |
|
|
|
|
|
|
|
| Thomas, M Albert |
|
| Virginia Elderkin-Thompson, M Albert Thomas, Nader Binesh, Jim Mintz, Ebrahim Haroon, Jennifer J Dunkin and Anand Kumar Brain Metabolites and Cognitive Function among Older Depressed and Healthy Individuals Using 2D MR Spectroscopy doi:10.1038/sj.npp.1300553 Neuropsychopharmacology 29, 2251-2257 | Abstract | Full text | PDF | |
|
|
|
| Olusola Ajilore, Ebrahim Haroon, Senthil Kumaran, Christine Darwin, Nader Binesh, Jim Mintz, Jacqueline Miller, M Albert Thomas and Anand Kumar Measurement of Brain Metabolites in Patients with type 2 Diabetes and Major Depression Using Proton Magnetic Resonance Spectroscopy doi:10.1038/sj.npp.1301248 Neuropsychopharmacology 32, 1224-1231 | Abstract | Full text | PDF | |
|
|
|
| Mark A Frye, June Watzl, Shida Banakar, Joseph O'Neill, Jim Mintz, Pablo Davanzo, Jeffrey Fischer, Jason W Chirichigno, Joseph Ventura, Shana Elman, John Tsuang, Irwin Walot and M Albert Thomas Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression doi:10.1038/sj.npp.1301387 Neuropsychopharmacology 32, 2490-2499 | Abstract | Full text | PDF | |
|
|
|
| Pablo Davanzo, M Albert Thomas, Kenneth Yue, Thomas Oshiro, Thomas Belin, Michael Strober and James McCracken Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder doi:10.1016/S0893-133X(00)00207-4 Neuropsychopharmacology 24, 359-369 | Abstract | Full text | PDF | |
|
|
|
| Thomas, Maria |
|
| Una D McCann, David Thorne, Martica Hall, Kathy Popp, Warren Avery, Helen Sing, Maria Thomas and Gregory Belenky The Effects of L-Dihydroxyphenylalanine on Alertness and Mood in  -Methyl-Para-Tyrosine-Treated Healthy Humansdoi:10.1016/0893-133X(94)00134-L Neuropsychopharmacology 13, 41-52 | Abstract | PDF | |
|
|
|
| Thomas, Mark J |
|
| Susan M Ferguson, Mark J Thomas and Terry E Robinson Morphine-Induced c-fos mRNA Expression in Striatofugal Circuits: Modulation by Dose, Environmental Context, and Drug History doi:10.1038/sj.npp.1300465 Neuropsychopharmacology 29, 1664-1674 | Abstract | Full text | PDF | |
|
|
|
| Patrick E Rothwell, Mark J Thomas and Jonathan C Gewirtz Distinct Profiles of Anxiety and Dysphoria during Spontaneous Withdrawal from Acute Morphine Exposure doi:10.1038/npp.2009.56 Neuropsychopharmacology 34, 2285-2295 | Abstract | Full text | PDF | |
|
|
|
| Thomas, Paul D |
|
| Andrew W Bergen, David V Conti, David Van Den Berg, Wonho Lee, Jinghua Liu, Dalin Li, Nan Guo, Huaiyu Mi, Paul D Thomas, Christina N Lessov-Schlaggar, Ruth Krasnow, Yungang He, Denise Nishita, Ruhong Jiang, Jennifer B McClure, Elizabeth Tildesley, Hyman Hops, Rachel F Tyndale, Neal L Benowitz, Caryn Lerman and Gary E Swan Dopamine Genes and Nicotine Dependence in Treatment-Seeking and Community Smokers doi:10.1038/npp.2009.52 Neuropsychopharmacology 34, 2252-2264 | Abstract | Full text | PDF | |
|
|
|
| Thomas, Sarah |
|
| Joyce L W Yau, June Noble, Sarah Thomas, Robert Kerwin, Phillip E Morgan, Stafford Lightman, Jonathan R Seckl and Carmine M Pariante The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice doi:10.1038/sj.npp.1301389 Neuropsychopharmacology 32, 2520-2529 | Abstract | Full text | PDF | |
|
|
|
| Thomas, Suzanne E |
|
| David J Drobes, Raymond F Anton, Suzanne E Thomas and Konstantin Voronin A Clinical Laboratory Paradigm for Evaluating Medication Effects on Alcohol Consumption: Naltrexone and Nalmefene doi:10.1038/sj.npp.1300101 Neuropsychopharmacology 28, 755-764 | Abstract | Full text | PDF | |
|
|
|
| Thomas, Theresa Currier |
|
| Theresa Currier Thomas, David K Grandy, Greg A Gerhardt and Paul EA Glaser Decreased Dopamine D4 Receptor Expression Increases Extracellular Glutamate and Alters Its Regulation in Mouse Striatum doi:10.1038/npp.2008.74 Neuropsychopharmacology 34, 436-445 | Abstract | Full text | PDF | |
|
|
|
| Thome, Johannes |
|
| Andreas Reif, Michael Rösler, Christine M Freitag, Marc Schneider, Andrea Eujen, Christian Kissling, Denise Wenzler, Christian P Jacob, Petra Retz-Junginger, Johannes Thome, Klaus-Peter Lesch and Wolfgang Retz Nature and Nurture Predispose to Violent Behavior: Serotonergic Genes and Adverse Childhood Environment doi:10.1038/sj.npp.1301359 Neuropsychopharmacology 32, 2375-2383 | Abstract | Full text | PDF | |
|
|
|
| Venetia Zachariou, Johannes Thome, Kavita Parikh and Marina R Picciotto Upregulation of Galanin Binding Sites and GalR1 mRNA Levels in the Mouse Locus Coeruleus Following Chronic Morphine Treatments and Precipitated Morphine Withdrawal doi:10.1016/S0893-133X(00)00094-4 Neuropsychopharmacology 23, 127-137 | Abstract | Full text | PDF | |
|
|
|
| Thompson, Linda |
|
| Frank P Bymaster, Laura J Dreshfield-Ahmad, Penny G Threlkeld, Janice L Shaw, Linda Thompson, David L Nelson, Susan K Hemrick-Luecke and David T Wong Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors doi:10.1016/S0893-133X(01)00298-6 Neuropsychopharmacology 25, 871-880 | Abstract | Full text | PDF | |
|
|
|
| Thompson, Murray R |
|
| Murray R Thompson, Kong M Li, Kelly J Clemens, Clint G Gurtman, Glenn E Hunt, Jennifer L Cornish and Iain S McGregor Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA ('Ecstasy') in Rats doi:10.1038/sj.npp.1300347 Neuropsychopharmacology 29, 694-704 | Abstract | Full text | PDF | |
|
|
|
| Heidi R Quinn, Izuru Matsumoto, Paul D Callaghan, Leonora E Long, Jonathon C Arnold, Nathan Gunasekaran, Murray R Thompson, Bronwyn Dawson, Paul E Mallet, Mohammed A Kashem, Haruka Matsuda-Matsumoto, Takeshi Iwazaki and Iain S McGregor Adolescent Rats Find Repeated  9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposuredoi:10.1038/sj.npp.1301475 Neuropsychopharmacology 33, 1113-1126 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
